JAAD International (Sep 2023)

Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class

  • Ahmed Bagit, BSc,
  • Khalad Maliyar, MD,
  • Jorge R. Georgakopoulos, MD,
  • Brian Rankin, BSc,
  • Alexander Rimke, MSc,
  • Asfandyar Mufti, MD,
  • Heather Le, CRC,
  • Ronald Vender, MD,
  • Vimal H. Prajapati, MD,
  • Jensen Yeung, MD

Journal volume & issue
Vol. 12
pp. 136 – 138

Abstract

Read online

No abstracts available.

Keywords